Hossein Khalili to Hydroxychloroquine
This is a "connection" page, showing publications Hossein Khalili has written about Hydroxychloroquine.
Connection Strength
0.214
-
Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting. Int Immunopharmacol. 2021 Jul; 96:107636.
Score: 0.165
-
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. Daru. 2020 Dec; 28(2):625-634.
Score: 0.039
-
A Randomized Clinical Trial of the Efficacy and Safety of Interferon ß-1a in Treatment of Severe COVID-19. Antimicrob Agents Chemother. 2020 08 20; 64(9).
Score: 0.010